Document is current
Any future updates will be listed below
-
Authors
Ismailov, Rovshan M.
Aceña, Álvaro
Khasanova, Zaytuna D.
-
Funding
Funding for this research was provided by:
Pfizer (75860381)
CMDAT Research Foundation (75860381)
- License Information
-
More Information
Article History
Accepted: 7 March 2024
First Online: 15 March 2024
Declarations
:
: This study was determined as exempt by Pearl IRB on November 1, 2022, and was performed in accordance with the ethical standards of the Declaration of Helsinki. Our informed consent explained the purpose of our study, intended use of collected data, and the guarantee of anonymity of data.
